en · de · es · fr · pt
peptide-index.peptides6823.com › Faq › Identity And Research Context — Explained

Identity And Research Context — Explained

By Editorial Desk · published 2026-03-22 · last reviewed 2026-05-03 · Faq

This is a working overview of lipolysis, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-05-03 and is reviewed periodically as new material appears.

Identity and Research Context

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.

Measurement and Storage Practices

Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Aod-9604 at a glance

PropertyValueNotes
Common nameAOD-9604Development code used in scientific literature.
Chemical classSynthetic peptideFragment of human growth hormone.
Amino acid length16 residuesMatches hGH region 176-191.
AppearanceWhite to off-white powderTypical lyophilized peptide solid.
SolubilitySoluble in waterDissolves in aqueous media; exact behavior depends on salt form.

Background And Research Context

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

Related pages on this site

Mechanism and Regulatory Status

Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.

Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.

Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.

Background from the literature

=== Introduction and History of DNA Legos === DNA origami has been used to assemble a range of two-dimensional and three-dimensional nanostructures; however, each different structure requires a new design and a new set of scaffold strand and staple strands. This limits scalability and structure yield efficiency. Researchers have developed “DNA brick” or “DNA Lego” technologies by making single stranded tiles (SSTs). SSTs allow for the production of larger structures without a scaffold strand and with the ease of arranging the predesigned blocks into bigger structures. Much like how actual Lego bricks allow specific assembly configurations, DNA Lego bricks bind at specific sites to form a range of shapes. Appropriate selection of blocks to include in an assembly mixture allows production of a variety of complex 3D shapes without a scaffold strand and without having to design an entirely different structure. With the DNA Lego brick approach, the DNA strand binds to neighboring strands to form a “brick”. By selecting subsets of strands to form a larger shape, researchers demonstrated that many 3D structures could be assembled from the same general set of components or bricks. The authors called this a “voxel-based” design strategy meaning that each 8-base pair interaction between bricks defines a voxel with dimensions 2.5 by 2.5 nm. Since each DNA interaction can be analogized to Lego construction, we can also claim one voxel corresponds to one stud Lego brick . This scaffold-free strategy has also been extended to larger multicomponent structures.

WHO referred to the incident as one of the largest food safety events it has had to deal with, and stated it would be difficult to restore the confidence of Chinese consumers in baby formula. It saw regulation failing to keep pace with the rapid development of the food and industrial production as opening the gates to all types of misbehaviour and malfeasance. The spokesman said the scale of the problem proved it was "clearly not an isolated accident, [but] a large-scale intentional activity to deceive consumers for simple, basic, short-term profits". WHO Director-General Margaret Chan reminded Chinese mothers that breastfeeding was the best way to provide nutrition to infants while avoiding a risk of melamine exposure. She noted that the scandal showed "the impact and power of globalisation" in food distribution and highlighted "the importance of seamless cooperation from farm to consumer".

2003 saw Helton involved in the closest NL batting race in history, as he hit .35849, while St. Louis Cardinals first baseman Albert Pujols edged him out by posting a .35871 batting average to win the batting crown. Helton also had 33 home runs, 117 RBI, 135 runs, 49 doubles and five triples. He won his fourth Player of the Month honor for April, when he hit .337 with six home runs, 27 RBI, 28 runs, 11 doubles and 24 walks. He also appeared in his fourth consecutive All-Star Game. During the 2004 season, Helton again finished second in the NL batting race, as he hit .347, while San Francisco Giants left fielder Barry Bonds hit .362. Helton also had 32 home runs and 96 RBI on the season. He became the first player in MLB history to hit at least .315 with 25 home runs and 95 RBI in each of his first seven full seasons in the majors. He became only the third player in MLB history to accomplish that feat during any seven-year stretch in a career (Lou Gehrig and Babe Ruth are the others). He set a franchise record by hitting at least 30 home runs in six consecutive seasons. Helton was named to his team-record fifth consecutive All-Star Game and won his third Gold Glove during the season. In 2005, Helton was placed on the disabled list (July 26 – August 9) for the first time in his career, missing time with a strained left calf muscle. He hit .320 with 20 home runs, 79 RBI, 92 runs, and 45 doubles for the season. He was under 1.000 in OPS (finished with .979 OPS) for the first time since 1999, and was also left off the NL All-Star roster for the first time since that same year.

== Pre-Proto-Hassuna == More recently, the concept of a very early 'Pre-Proto-Hassuna' pottery tradition has been introduced by some scholars. This has been prompted by more recent discoveries of still earlier pottery traditions. Pre-Proto-Hassuna refers to the Late Neolithic period in Upper Mesopotamia when the ceramic containers were just being introduced. The pottery vessels were still very few in number in these early settlements. At that time, the main emphasis was on the pottery with a mineral temper, as opposed to the plant-tempered pottery which came to predominate later. The time frame for this period was about 7000-6700 BC, and at this time stone vessels and White Ware were still being used in addition to pottery. Because of the narrow local emphasis in many pottery studies as of now, these earliest pottery traditions may be known in literature as:

Sources: en.wikipedia.org

Further detail

Driessen HP, de Jong WW, Tesser GI, Bloemendal H (1985). "The mechanism of N-terminal acetylation of proteins". CRC Crit. Rev. Biochem. 18 (4): 281–325. doi:10.3109/10409238509086784. PMID 3902358. Glembotski CC (1982). "Characterization of the peptide acetyltransferase activity in bovine and rat intermediate pituitaries responsible for the acetylation of beta-endorphin and alpha-melanotropin". J. Biol. Chem. 257 (17): 10501–9. doi:10.1016/S0021-9258(18)34046-8. PMID 6286657. O'Donohue TL (1983). "Identification of endorphin acetyltransferase in rat brain and pituitary gland". J. Biol. Chem. 258 (4): 2163–7. doi:10.1016/S0021-9258(18)32902-8. PMID 6296134. Tsunasawa S, Kamitani K, Narita K (February 1980). "Partial purification and properties of the amino-terminal amino acid-acetylating enzyme from hen's oviduct". J. Biochem. 87 (2): 645–50. doi:10.1093/oxfordjournals.jbchem.a132789. PMID 6244269.

Despite his advanced age and having stepped down as prime minister, Mahathir remains active on the international stage, frequently travelling, delivering speeches, and continuing to voice his views and influence both domestically and globally. Shortly after Malaysia entered its first movement control order in March 2020, Mahathir underwent self-quarantine at home after having close contact with Bandar Kuching MP Kelvin Yii Lee Wuen, who later tested positive for COVID-19. He formed the Homeland Fighter's Party (PEJUANG) in August 2020. Four other MPs joined the new party, including Mahathir's son Mukhriz. The party was registered in July 2021. In August 2021, Mahathir and other MPs protested in Merdeka Square, calling for Muhyiddin's resignation over the government's response to the COVID-19 pandemic, after being blocked from entering parliament by police. In April 2022, UMNO president Ahmad Zahid Hamidi filed a defamation lawsuit against Mahathir. In June 2022, Mahathir made irrendentist comments by stating that Singapore and the Riau Islands of Indonesia was once owned by Johor, and argued the state should claim them as part of Malaysia. In September 2022, Mahathir said he was open to becoming the prime minister for a third time if there were no other suitable candidates. Having previously said he would not defend his Langkawi parliamentary seat, he announced he would contest the 2022 general election. In the election on 19 November, Mahathir lost his seat and election deposit, marking his first defeat in 53 years.

It took him several years to disengage from molecular biology because exciting discoveries continued to be made, including the discovery of alternative splicing and the discovery of restriction enzymes, which helped make possible genetic engineering. Eventually, in the 1980s, Crick was able to devote his full attention to his other interest, consciousness. His autobiographical book, What Mad Pursuit: A Personal View of Scientific Discovery, includes a description of why he left molecular biology and switched to neuroscience. Upon taking up work in theoretical neuroscience, Crick was struck by several things:

Sources: en.wikipedia.org

Background from the literature

The appearance of the princess before the judge took place on February 8 amid great national and international media expectation. The impact on public opinion was reflected in the CIS barometer of May, in which the monarchy failed again with a score of 3.72. On June 2, 2014, the abdication of Juan Carlos was announced, after nearly 39 years of reign. He had taken the decision five months earlier, on January 5, his birthday, and had communicated it to Prime Minister Mariano Rajoy on March 31. Pro-republicans reacted to the abdication by holding rallies in several cities calling for a referendum to decide the form of government. This claim reappeared in the debate held in the Congress of Deputies on June 11 to approve the organic abdication law. It was presented and supported by the formations that voted against said law: the 19 seats that made up United Left-Plural Left, Geroa Bai, Compromís, New Canaries, Republican Left of Catalonia and BNG. The law was approved by an overwhelming majority: 299 deputies of the PP, PSOE, UPyD, Asturias Forum and Navarrese People's Union. On June 18, Juan Carlos signed the law, which was the last official act of his reign. The following day, Felipe VI was proclaimed King by the Cortes.

==== Thick-client ==== A thick-client LIMS is a more traditional client/server architecture, with some of the system residing on the computer or workstation of the user (the client) and the rest on the server. The LIMS software is installed on the client computer, which does all of the data processing. Later it passes information to the server, which has the primary purpose of data storage. Most changes, upgrades, and other modifications will happen on the client side. This was one of the first architectures implemented into a LIMS, having the advantage of providing higher processing speeds (because processing is done on the client and not the server). Additionally, thick-client systems have also provided more interactivity and customization, though often at a greater learning curve. The disadvantages of client-side LIMS include the need for more robust client computers and more time-consuming upgrades, as well as a lack of base functionality through a web browser. The thick-client LIMS can become web-enabled through an add-on component. Although there is a claim of improved security through the use of a thick-client LIMS, this is based on the misconception that "only users with the client application installed on their PC can access server side information". This secrecy-of-design reliance is known as security through obscurity and ignores an adversary's ability to mimic client-server interaction through, for example, reverse engineering, network traffic interception, or simply purchasing a thick-client license.

The preconditions to the development of a living cell like the LUCA are known, though disputed in detail: a habitable world is formed with a supply of minerals and liquid water and sources of free energy inflows such as our Sun and geothermal heat. Prebiotic synthesis creates a range of simple organic compounds, which are assembled into polymers such as proteins and RNA. On the other side, the process after the LUCA is readily understood: biological evolution caused the development of a wide range of species with varied forms and biochemical capabilities. However, the derivation of the LUCA from simple components is far from understood. Although Earth remains the only place where life is known, the science of astrobiology seeks evidence of life on other planets. The 2015 NASA strategy on the origin of life aimed to solve the puzzle by identifying interactions, intermediary structures and functions, energy sources, and environmental factors that contributed to evolvable macromolecular systems, and mapping the chemical landscape of potential primordial informational polymers. The advent of such polymers was most likely a critical step in prebiotic chemical evolution. Those polymers derived, in turn, from simple organic compounds such as nucleobases, amino acids, and sugars, likely formed by reactions in the environment. A successful theory of the origin of life must explain how all these chemicals came into being.

== Side effects == Very common (incidence > 10%) adverse effects include constipation, dry mouth, and drowsiness at the beginning of treatment. Common (1% < incidence ≤ 10%) adverse effects include drowsiness during maintenance therapy, tremor, headache, dizziness, vertigo, and weakness. Uncommon (0.1% < incidence ≤ 1%) adverse effects include weight gain.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Is AOD-9604 the same as human growth hormone?

No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.

Why is it called hGH fragment 176-191?

The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.

How is AOD-9604 typically analyzed?

Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.

Network